The overactivated IFN-γ and IFN-α axes converge to drive pathological antigen presentation and reactivation of the pathways, creating a vicious cycle that sustains downstream targets (STAT, MYC, Bcl-2, Bcl-xL), facilitating tumor cell proliferation, migration, and drug resistance. This evidence concerns the gene IFNG and neoplasm.